At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
Desflurane Inhalant Product +1 moredrug
Likely dose
Desflurane Inhalant Product 0.2µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of General Anesthesia With Propofol Versus Desflurane on Oxidative Stress and Inflammation in Obese Patients Scheduled for Bariatric Surgery
Centre Hospitalier Universitaire Saint Pierre·interventional·Posted Jan 31, 2018·Updated Feb 9, 2018
In Brief
A Phase 4 clinical trial evaluating Desflurane Inhalant Product and Propofol for Anesthesia and Obesity. Completed, enrolled 40 participants.
Detailed Summary
Evaluate the effects of propofol compared with desflurane on oxidative stress and inflammation markers in obese patients undergoing scheduled bariatric surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia, Obesity
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
Primary CompletionOct 2015
Study CompletionSep 2016
First PostedJan 2018
TodayJul 2026
First PostedJan 31, 2018
Enrollment StartJan 1, 2015
Primary CompletionOct 1, 2015
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.4 years ago
Interventions
Desflurane Inhalant Productdrug
General anesthesia will be induced with sufentanyl (0.2µg/kg) and thiopental (5mg/kg) and maintained by desflurane
Propofoldrug
General anesthesia will be induced with propofol (2mg/kg) and sufentanyl (0.2µg/kg) and maintained by propofol in a target-controlled infusion mode